Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1993 Mar;67(3):1262–1268. doi: 10.1128/jvi.67.3.1262-1268.1993

Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans.

J Simons 1, M Kutubuddin 1, M Chow 1
PMCID: PMC237492  PMID: 7679744

Abstract

Poliovirus-specific cellular immune responses were identified in the peripheral blood mononucleocytes of Sabin-immunized human donors by using a proliferation assay. Complement depletion and monoclonal antibody inhibition studies suggest that the effector population is the major histocompatibility complex (MHC) class II-restricted CD4+ T-helper cell. Immune lymphocytes proliferated to polyacrylamide gel purified-capsid proteins VP1, VP2, and VP3 and, in some individuals, to synthetic VP4, indicating the presence of T-cell epitopes in each of these proteins. Using synthetic peptides, T-cell epitopes have been mapped to specific regions in VP1 which lie near previously identified neutralizing antibody recognition sites. Human leukocyte antigen (HLA) typing of the donor individuals indicated that no MHC class II molecule was held in common between all four donor individuals. Thus, the positive responses observed with peptides p182-201 and p244-261 in three of four and four of four donors suggest that these peptides contain epitopes presented by at least two different MHC molecules. Antibody-blocking experiments suggest that an epitope within VP1 residues 244 to 264 is presented by HLA DQ3.

Full text

PDF
1262

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck M. A., Tracy S. M. Evidence for a group-specific enteroviral antigen(s) recognized by human T cells. J Clin Microbiol. 1990 Aug;28(8):1822–1827. doi: 10.1128/jcm.28.8.1822-1827.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beck M. A., Tracy S. M. Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s). J Virol. 1989 Oct;63(10):4148–4156. doi: 10.1128/jvi.63.10.4148-4156.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodmer J. G., Marsh S. G., Albert E. Nomenclature for factors of the HLA system, 1989. Immunol Today. 1990 Jan;11(1):3–10. doi: 10.1016/0167-5699(90)90003-r. [DOI] [PubMed] [Google Scholar]
  4. Brown J. H., Jardetzky T., Saper M. A., Samraoui B., Bjorkman P. J., Wiley D. C. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature. 1988 Apr 28;332(6167):845–850. doi: 10.1038/332845a0. [DOI] [PubMed] [Google Scholar]
  5. Chicz R. M., Urban R. G., Lane W. S., Gorga J. C., Stern L. J., Vignali D. A., Strominger J. L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 1992 Aug 27;358(6389):764–768. doi: 10.1038/358764a0. [DOI] [PubMed] [Google Scholar]
  6. Chow M., Baltimore D. Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7518–7521. doi: 10.1073/pnas.79.23.7518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chow M., Yabrov R., Bittle J., Hogle J., Baltimore D. Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. Proc Natl Acad Sci U S A. 1985 Feb;82(3):910–914. doi: 10.1073/pnas.82.3.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fricks C. E., Icenogle J. P., Hogle J. M. Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. J Virol. 1985 Jun;54(3):856–859. doi: 10.1128/jvi.54.3.856-859.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Icenogle J. P., Minor P. D., Ferguson M., Hogle J. M. Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J Virol. 1986 Oct;60(1):297–301. doi: 10.1128/jvi.60.1.297-301.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ing P. M., Falk J. A., Letarte M., Delovitch T. L., Falk R. E. Serologic cross-reaction of murine and human Ia antigens. Transplant Proc. 1979 Dec;11(4):1745–1747. [PubMed] [Google Scholar]
  11. Jubelt B., Ropka S. L., Goldfarb S. J., Janavs J. L. Anti-thymocyte serum delays clearance of poliovirus from the mouse central nervous system. J Neuroimmunol. 1989 May;22(3):223–232. doi: 10.1016/0165-5728(89)90020-9. [DOI] [PubMed] [Google Scholar]
  12. Katrak K., Mahon B. P., Minor P. D., Mills K. H. Cellular and humoral immune responses to poliovirus in mice: a role for helper T cells in heterotypic immunity to poliovirus. J Gen Virol. 1991 May;72(Pt 5):1093–1098. doi: 10.1099/0022-1317-72-5-1093. [DOI] [PubMed] [Google Scholar]
  13. Kilgus J., Jardetzky T., Gorga J. C., Trzeciak A., Gillessen D., Sinigaglia F. Analysis of the permissive association of a malaria T cell epitope with DR molecules. J Immunol. 1991 Jan 1;146(1):307–315. [PubMed] [Google Scholar]
  14. Kinnunen L., Huovilainen A., Pöyry T., Hovi T. Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts. J Gen Virol. 1990 Feb;71(Pt 2):317–324. doi: 10.1099/0022-1317-71-2-317. [DOI] [PubMed] [Google Scholar]
  15. Kutubuddin M., Simons J., Chow M. Identification of T-helper epitopes in the VP1 capsid protein of poliovirus. J Virol. 1992 May;66(5):3042–3047. doi: 10.1128/jvi.66.5.3042-3047.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kutubuddin M., Simons J., Chow M. Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions. J Virol. 1992 Oct;66(10):5967–5974. doi: 10.1128/jvi.66.10.5967-5974.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leclerc C., Deriaud E., Mimic V., van der Werf S. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. J Virol. 1991 Feb;65(2):711–718. doi: 10.1128/jvi.65.2.711-718.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Minor P. D. Antigenic structure of picornaviruses. Curr Top Microbiol Immunol. 1990;161:121–154. doi: 10.1007/978-3-642-75602-3_5. [DOI] [PubMed] [Google Scholar]
  19. Nomoto A., Omata T., Toyoda H., Kuge S., Horie H., Kataoka Y., Genba Y., Nakano Y., Imura N. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A. 1982 Oct;79(19):5793–5797. doi: 10.1073/pnas.79.19.5793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Page G. S., Mosser A. G., Hogle J. M., Filman D. J., Rueckert R. R., Chow M. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol. 1988 May;62(5):1781–1794. doi: 10.1128/jvi.62.5.1781-1794.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Palker T. J., Matthews T. J., Langlois A., Tanner M. E., Martin M. E., Scearce R. M., Kim J. E., Berzofsky J. A., Bolognesi D. P., Haynes B. F. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol. 1989 May 15;142(10):3612–3619. [PubMed] [Google Scholar]
  22. Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol. 1989 Dec;19(12):2237–2242. doi: 10.1002/eji.1830191209. [DOI] [PubMed] [Google Scholar]
  23. Roivainen M., Hovi T. Cleavage of VP1 and modification of antigenic site 1 of type 2 polioviruses by intestinal trypsin. J Virol. 1988 Sep;62(9):3536–3539. doi: 10.1128/jvi.62.9.3536-3539.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Roivainen M., Hovi T. Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine. J Virol. 1987 Dec;61(12):3749–3753. doi: 10.1128/jvi.61.12.3749-3753.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Roivainen M., Närvänen A., Korkolainen M., Huhtala M. L., Hovi T. Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique. Virology. 1991 Jan;180(1):99–107. doi: 10.1016/0042-6822(91)90013-2. [DOI] [PubMed] [Google Scholar]
  26. Sinigaglia F., Guttinger M., Kilgus J., Doran D. M., Matile H., Etlinger H., Trzeciak A., Gillessen D., Pink J. R. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature. 1988 Dec 22;336(6201):778–780. doi: 10.1038/336778a0. [DOI] [PubMed] [Google Scholar]
  27. Vahlne A., Horal P., Eriksson K., Jeansson S., Rymo L., Hedström K. G., Czerkinsky C., Holmgren J., Svennerholm B. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10744–10748. doi: 10.1073/pnas.88.23.10744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wang K. G., Sun L. Z., Jubelt B., Waltenbaugh C. Cell-mediated immune responses to poliovirus. I. Conditions for induction, characterization of effector cells, and cross-reactivity between serotypes for delayed hypersensitivity and T cell proliferative responses. Cell Immunol. 1989 Apr 1;119(2):252–262. doi: 10.1016/0008-8749(89)90242-6. [DOI] [PubMed] [Google Scholar]
  29. Wang K., Sun L., Jubelt B., Waltenbaugh C. Cell-mediated immune responses to poliovirus II. Survey of delayed hypersensitivity and T-cell proliferative responses in inbred mouse strains. Viral Immunol. 1990 Summer;3(2):111–117. doi: 10.1089/vim.1990.3.111. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES